$NWPX
NORTHWEST PIPE CO

2017 Q1 Form 10-Q Financial Statement

#000143774917007835 Filed on May 03, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $29.66M $29.36M
YoY Change 1.02% -65.41%
Cost Of Revenue $28.89M $39.37M
YoY Change -26.62% -51.39%
Gross Profit $1.243M -$5.750M
YoY Change -121.62% -247.78%
Gross Profit Margin 4.19% -19.59%
Selling, General & Admin $3.840M $4.599M
YoY Change -16.5% -34.06%
% of Gross Profit 308.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.729M $2.181M
YoY Change -20.72% -17.07%
% of Gross Profit 139.1%
Operating Expenses $3.840M $4.599M
YoY Change -16.5% -34.06%
Operating Profit -$3.478M -$10.19M
YoY Change -65.88% 230.59%
Interest Expense $137.0K $119.0K
YoY Change 15.13% -71.46%
% of Operating Profit
Other Income/Expense, Net -$89.00K $40.00K
YoY Change -322.5% -9.09%
Pretax Income -$3.704M -$10.12M
YoY Change -63.38% 199.79%
Income Tax -$162.0K -$532.0K
% Of Pretax Income
Net Earnings -$3.868M -$9.583M
YoY Change -59.64% 356.12%
Net Earnings / Revenue -13.04% -32.64%
Basic Earnings Per Share -$1.00
Diluted Earnings Per Share -$406.3K -$1.00
COMMON SHARES
Basic Shares Outstanding 9.604M 9.572M
Diluted Shares Outstanding 9.604M 9.572M

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.80M $9.400M
YoY Change 121.28% 9300.0%
Cash & Equivalents $20.81M $9.402M
Short-Term Investments
Other Short-Term Assets $1.800M $1.500M
YoY Change 20.0% -88.72%
Inventory $16.95M $29.38M
Prepaid Expenses
Receivables $63.70M $63.40M
Other Receivables $0.00 $3.400M
Total Short-Term Assets $103.2M $107.1M
YoY Change -3.59% -34.45%
LONG-TERM ASSETS
Property, Plant & Equipment $116.8M $130.2M
YoY Change -10.25% -1.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.05M $11.96M
YoY Change -7.56% -38.08%
Total Long-Term Assets $127.9M $142.2M
YoY Change -10.03% -9.71%
TOTAL ASSETS
Total Short-Term Assets $103.2M $107.1M
Total Long-Term Assets $127.9M $142.2M
Total Assets $231.1M $249.2M
YoY Change -7.26% -22.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.627M $3.739M
YoY Change -3.0% -60.31%
Accrued Expenses $7.140M $15.49M
YoY Change -53.9% 70.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $300.0K $400.0K
YoY Change -25.0% -78.95%
Total Short-Term Liabilities $12.00M $23.36M
YoY Change -48.66% 6.62%
LONG-TERM LIABILITIES
Long-Term Debt $500.0K $700.0K
YoY Change -28.57% -97.2%
Other Long-Term Liabilities $11.85M $12.53M
YoY Change -5.4% -22.29%
Total Long-Term Liabilities $11.85M $12.53M
YoY Change -5.4% -22.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.00M $23.36M
Total Long-Term Liabilities $11.85M $12.53M
Total Liabilities $25.43M $42.03M
YoY Change -39.5% -45.58%
SHAREHOLDERS EQUITY
Retained Earnings $88.05M $91.60M
YoY Change -3.87% -28.7%
Common Stock $119.0M $117.2M
YoY Change 1.6% 0.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $205.7M $207.2M
YoY Change
Total Liabilities & Shareholders Equity $231.1M $249.2M
YoY Change -7.26% -22.3%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$3.868M -$9.583M
YoY Change -59.64% 356.12%
Depreciation, Depletion And Amortization $1.729M $2.181M
YoY Change -20.72% -17.07%
Cash From Operating Activities -$282.0K $1.189M
YoY Change -123.72% -95.16%
INVESTING ACTIVITIES
Capital Expenditures $529.0K $736.0K
YoY Change -28.13% -80.05%
Acquisitions
YoY Change
Other Investing Activities $30.00K
YoY Change
Cash From Investing Activities -$504.0K -$736.0K
YoY Change -31.52% -79.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -236.0K -1.360M
YoY Change -82.65% -93.66%
NET CHANGE
Cash From Operating Activities -282.0K 1.189M
Cash From Investing Activities -504.0K -736.0K
Cash From Financing Activities -236.0K -1.360M
Net Change In Cash -1.022M -907.0K
YoY Change 12.68% 120.68%
FREE CASH FLOW
Cash From Operating Activities -$282.0K $1.189M
Capital Expenditures $529.0K $736.0K
Free Cash Flow -$811.0K $453.0K
YoY Change -279.03% -97.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 nwpx Estimated Cost Of Epa Selected Remedy
EstimatedCostOfEPASelectedRemedy
1050000000
CY2017Q1 nwpx Estimated Time To Complete Selected Epa Remedy
EstimatedTimeToCompleteSelectedEPARemedy
P13Y
CY2017Q1 nwpx Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
17683000
CY2016Q4 nwpx Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
19810000
CY2017Q1 nwpx Minimum Performance Awards Issued Multiplier
MinimumPerformanceAwardsIssuedMultiplier
0
CY2017Q1 nwpx Number Of Active Stock Incentive Plans
NumberOfActiveStockIncentivePlans
1
CY2017Q1 nwpx Number Of Inactive Stock Option Plans
NumberOfInactiveStockOptionPlans
1
CY2017Q1 nwpx Number Of Potentially Responsible Parties
NumberOfPotentiallyResponsibleParties
100
CY2017Q1 nwpx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
112000
CY2016Q1 nwpx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
1233000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3627000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5267000
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7140000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10925000
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
87024000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
85604000
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1388000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1483000
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
118927000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
118680000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
271000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
178000
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
496000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
515000
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
261000
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-8000
CY2017Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
42000
CY2016Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
41000
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
128000
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
131000
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
196000
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
94000
CY2017Q1 us-gaap Assets
Assets
231114000
CY2016Q4 us-gaap Assets
Assets
241555000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
103212000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
112180000
CY2017Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
6228000
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
6267000
CY2017Q1 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
940000
CY2016Q4 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
2038000
CY2017Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
27000
CY2016Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-20000
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
133000
CY2016Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
131000
CY2017Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
288000
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
325000
CY2017Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
CY2016Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
71000
CY2017Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
539000
CY2016Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
602000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20807000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21829000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10309000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9402000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1022000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-907000
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9604811
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9601011
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9604811
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9601011
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
96000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
96000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3773000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9615000
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
28886000
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
39365000
CY2017Q1 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear
45063000
CY2016Q4 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear
43663000
CY2017Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
6202000
CY2016Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
6209000
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-238000
CY2016Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-602000
CY2017Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1044000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1282000
CY2017Q1 us-gaap Depreciation
Depreciation
1850000
CY2016Q1 us-gaap Depreciation
Depreciation
2181000
CY2017Q1 us-gaap Derivative Assets
DerivativeAssets
26000
CY2016Q4 us-gaap Derivative Assets
DerivativeAssets
58000
CY2017Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0
CY2016Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-200000
CY2017Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
14000
CY2016Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
8000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.054
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.053
CY2017Q1 us-gaap Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
0
CY2017Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-30000
CY2016Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-415000
CY2017Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
19000
CY2016Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-10000
CY2017Q1 us-gaap Gross Profit
GrossProfit
780000
CY2016Q1 us-gaap Gross Profit
GrossProfit
-5437000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4089000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10115000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-221000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-532000
CY2017Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-6678000
CY2016Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-5606000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1714000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-735000
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3657000
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1263000
CY2017Q1 us-gaap Increase Decrease In Cost In Excess Of Billing On Uncompleted Contract
IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract
2498000
CY2016Q1 us-gaap Increase Decrease In Cost In Excess Of Billing On Uncompleted Contract
IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract
-4434000
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2038000
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-119000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-387000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-285000
CY2015Q1 us-gaap Insurance Recoveries
InsuranceRecoveries
2600000
CY2017Q1 us-gaap Interest Expense
InterestExpense
137000
CY2016Q1 us-gaap Interest Expense
InterestExpense
119000
CY2017Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
323000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
40000
CY2017Q1 us-gaap Inventory Net
InventoryNet
16954000
CY2016Q4 us-gaap Inventory Net
InventoryNet
19037000
CY2017Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
729000
CY2016Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
773000
CY2017Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13117000
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
15411000
CY2017Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
2305000
CY2016Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
2351000
CY2017Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1209000
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1235000
CY2017Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2000000
CY2017Q1 us-gaap Liabilities
Liabilities
25427000
CY2016Q4 us-gaap Liabilities
Liabilities
32342000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
231114000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
241555000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11995000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18555000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-236000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1360000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-504000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-736000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-282000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1189000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-3868000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-9583000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3941000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10036000
CY2016Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-100000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11054000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11274000
CY2017Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-7000
CY2016Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-132000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
95000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-32000
CY2017Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-102000
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11849000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11903000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40000
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
24000
CY2016Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
31000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
529000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
736000
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1772000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2096000
CY2017Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
25000
CY2016Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116848000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
118101000
CY2017Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
18616000
CY2016Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
25555000
CY2017Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
100000
CY2016Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
96000
CY2017Q1 us-gaap Restructuring Charges
RestructuringCharges
881000
CY2016Q1 us-gaap Restructuring Charges
RestructuringCharges
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
88052000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
91920000
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
29666000
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
33928000
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3840000
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4599000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
271000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
178000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
26000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
24.97
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
26000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
26000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
24.97
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
24.97
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y284D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
205687000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
209213000
CY2017Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4900000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4900000
CY2017Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2016Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9604000
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9572000
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9604000
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9572000
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9604000
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9572000

Files In Submission

Name View Source Status
0001437749-17-007835-index-headers.html Edgar Link pending
0001437749-17-007835-index.html Edgar Link pending
0001437749-17-007835.txt Edgar Link pending
0001437749-17-007835-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nwpx-20170331.xml Edgar Link completed
nwpx-20170331.xsd Edgar Link pending
nwpx-20170331_cal.xml Edgar Link unprocessable
nwpx-20170331_def.xml Edgar Link unprocessable
nwpx-20170331_lab.xml Edgar Link unprocessable
nwpx-20170331_pre.xml Edgar Link unprocessable
nwpx20170331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending